This inventor holds 1 USPTO granted patent. Top assignee: Staat Der Nederlanden, De Minister Van Defensie, Voor Deze: Het Hoofd. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovations of Petrus Theodorus Biessels
Introduction
Petrus Theodorus Biessels is a notable inventor based in Oegstgeest, Netherlands. He has made significant contributions to the field of hemoglobin research, particularly in the development of blood plasma expanders. His work is characterized by a focus on safety and efficacy, which is crucial in medical applications.
Latest Patents
Biessels holds a patent for a hemoglobin composition and its preparation. This invention relates to an essentially stroma-free hemoglobin composition that exhibits properties suitable for use as a universally applicable blood plasma expander. The composition is designed to have desirable oxygen affinity values, a favorable vascular retention time, and a substantial absence of toxic side effects. The hemoglobin is cross-linked intramolecularly through the beta-chains and polymerized with glutaraldehyde, utilizing specific chemical agents for effective cross-linking.
Career Highlights
Biessels is associated with the Ministry of Defence of the Netherlands, where he contributes his expertise in the field of medical innovations. His work has implications not only for military applications but also for broader medical uses, enhancing the safety and effectiveness of blood substitutes.
Collaborations
Biessels has collaborated with notable colleagues such as Wilhelmus Antonius Berbers and Willem Karel Bleeker. These partnerships have likely enriched his research and development efforts, leading to advancements in hemoglobin-based therapies.
Conclusion
Petrus Theodorus Biessels is a distinguished inventor whose work in hemoglobin composition has the potential to revolutionize blood plasma expanders. His innovative approach emphasizes safety and efficacy, making significant strides in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile